DnB Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.7M | Buy |
117,013
+3,148
| +3% | +$1.51M | 0.16% | 83 |
|
|
2026
Q1 | $56M | Sell |
113,865
-642
| -0.6% | -$348K | 0.2% | 86 |
|
|
2025
Q4 | $66.4M | Sell |
114,507
-12,342
| -10% | -$6.98M | 0.23% | 68 |
|
|
2025
Q3 | $61.5M | Sell |
126,849
-12,465
| -9% | -$5.8M | 0.23% | 70 |
|
|
2025
Q2 | $56.5M | Sell |
139,314
-58,897
| -30% | -$24.6M | 0.23% | 68 |
|
|
2025
Q1 | $98.6M | Sell |
198,211
-3,070
| -2% | -$1.66M | 0.45% | 44 |
|
|
2024
Q4 | $105M | Buy |
201,281
+2,810
| +1% | +$1.54M | 0.45% | 37 |
|
|
2024
Q3 | $123M | Buy |
198,471
+3,124
| +2% | +$1.85M | 0.55% | 33 |
|
|
2024
Q2 | $108M | Buy |
195,347
+19,671
| +11% | +$11.3M | 0.52% | 36 |
|
|
2024
Q1 | $102M | Sell |
175,676
-76,279
| -30% | -$42.8M | 0.53% | 35 |
|
|
2023
Q4 | $134M | Buy |
251,955
+203
| +0.1% | +$98.3K | 0.69% | 24 |
|
|
2023
Q3 | $127M | Sell |
251,752
-795
| -0.3% | -$424K | 0.76% | 23 |
|
|
2023
Q2 | $132M | Buy |
252,547
+14,545
| +6% | +$7.85M | 0.76% | 24 |
|
|
2023
Q1 | $137M | Sell |
238,002
-9,909
| -4% | -$5.58M | 0.87% | 19 |
|
|
2022
Q4 | $137M | Buy |
247,911
+4,084
| +2% | +$2.16M | 0.96% | 17 |
|
|
2022
Q3 | $124M | Sell |
243,827
-7,469
| -3% | -$4.18M | 0.95% | 18 |
|
|
2022
Q2 | $137M | Buy |
251,296
+76,057
| +43% | +$41.9M | 0.96% | 15 |
|
|
2022
Q1 | $104M | Sell |
175,239
-6,167
| -3% | -$3.54M | 0.62% | 31 |
|
|
2021
Q4 | $121M | Sell |
181,406
-2,280
| -1% | -$1.42M | 0.71% | 23 |
|
|
2021
Q3 | $105M | Buy |
183,686
+471
| +0.3% | +$259K | 0.68% | 26 |
|
|
2021
Q2 | $92.4M | Buy |
183,215
+17,218
| +10% | +$8.12M | 0.61% | 26 |
|
|
2021
Q1 | $75.8M | Sell |
165,997
-390
| -0.2% | -$186K | 0.55% | 31 |
|
|
2020
Q4 | $77.5M | Buy |
166,387
+58,139
| +54% | +$27.3M | 0.68% | 30 |
|
|
2020
Q3 | $47.8M | Buy |
108,248
+6,001
| +6% | +$2.48M | 0.51% | 36 |
|
|
2020
Q2 | $37M | Buy |
102,247
+4,106
| +4% | +$1.38M | 0.44% | 47 |
|
|
2020
Q1 | $27.8M | Sell |
98,141
-9,772
| -9% | -$3.08M | 0.41% | 45 |
|
|
2019
Q4 | $35.1M | Buy |
107,913
+8,756
| +9% | +$2.65M | 0.34% | 59 |
|
|
2019
Q3 | $28.9M | Buy |
99,157
+3,246
| +3% | +$930K | 0.33% | 61 |
|
|
2019
Q2 | $28.2M | Sell |
95,911
-3,439
| -3% | -$947K | 0.32% | 56 |
|
|
2019
Q1 | $27.2M | Sell |
99,350
-3,459
| -3% | -$861K | 0.31% | 62 |
|
|
2018
Q4 | $23M | Sell |
102,809
-3,497
| -3% | -$820K | 0.3% | 70 |
|
|
2018
Q3 | $25.9M | Buy |
106,306
+8,808
| +9% | +$2.03M | 0.29% | 66 |
|
|
2018
Q2 | $20.2M | Buy |
97,498
+2,900
| +3% | +$616K | 0.24% | 80 |
|
|
2018
Q1 | $19.5M | Buy |
94,598
+8,750
| +10% | +$1.84M | 0.24% | 85 |
|
|
2017
Q4 | $16.3M | Buy |
85,848
+2,300
| +3% | +$441K | 0.2% | 90 |
|
|
2017
Q3 | $15.8M | Sell |
83,548
-1,600
| -2% | -$290K | 0.21% | 91 |
|
|
2017
Q2 | $14.9M | Sell |
85,148
-500
| -0.6% | -$84K | 0.22% | 87 |
|
|
2017
Q1 | $13.2M | Buy |
85,648
+5,000
| +6% | +$764K | 0.21% | 92 |
|
|
2016
Q4 | $11.4M | Buy |
80,648
+1,700
| +2% | +$251K | 0.21% | 92 |
|
|
2016
Q3 | $12.6M | Buy |
78,948
+6,855
| +10% | +$1.06M | 0.25% | 90 |
|
|
2016
Q2 | $10.7M | Buy |
72,093
+1,100
| +2% | +$162K | 0.23% | 91 |
|
|
2016
Q1 | $10.1M | Buy |
70,993
+16,900
| +31% | +$2.26M | 0.21% | 95 |
|
|
2015
Q4 | $7.67M | Sell |
54,093
-100
| -0.2% | -$13.3K | 0.16% | 110 |
|
|
2015
Q3 | $6.63M | Buy |
54,193
+500
| +0.9% | +$65.1K | 0.17% | 112 |
|
|
2015
Q2 | $6.97M | Buy |
53,693
+6,800
| +15% | +$886K | 0.15% | 119 |
|
|
2015
Q1 | $6.3M | Sell |
46,893
-4,600
| -9% | -$593K | 0.14% | 129 |
|
|
2014
Q4 | $6.45M | Sell |
51,493
-1,700
| -3% | -$207K | 0.15% | 127 |
|
|
2014
Q3 | $6.47M | Buy |
53,193
+34,685
| +187% | +$4.22M | 0.14% | 116 |
|
|
2014
Q2 | $2.18M | Buy |
+18,508
| New | +$2.18M | 0.05% | 215 |
|
|
2013
Q4 | $1.11M | Hold |
10,008
| – | – | 0.03% | 228 |
|
|
2013
Q3 | $922K | Buy |
+10,008
| New | +$905K | 0.03% | 268 |
|
Other funds holding TMO
DnB Asset Management's TMO Position: Q2 2026 in Review
DnB Asset Management increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, buying an estimated $1.51M and bringing the position to 117,013 shares worth $58.7M. The position accounts for 0.16% of the portfolio, ranked #83.
DnB Asset Management first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. The position peaked at $137M in Q1 2023. 1,864 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- DnB Asset Management held 117,013 shares of Thermo Fisher Scientific worth $58.7M as of Q2 2026.
- DnB Asset Management bought 3,148 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.51M.
- Thermo Fisher Scientific made up 0.16% of DnB Asset Management's portfolio in Q2 2026, its #83 holding.
- DnB Asset Management first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
- DnB Asset Management's Thermo Fisher Scientific position peaked at $137M in Q1 2023.
- 1,864 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.